Quantum Biopharma Ltd (HUGE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access HUGE Annual Balance Sheets →
This balance sheet overview for Quantum Biopharma Ltd spans from Dec 31 2024 to Dec 31 2025, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Sep 30 2025) (Jun 30 2025) (Mar 31 2025) (Dec 31 2024)
Assets
Cash And Cash Equivalents1.91
Cash & Short-term Investments1.00
Other Receivables0.00
Inventories0.05
Other Current Assets0.00
Total Current Assets6.48
Equipment/Property/Plant Net0.07
Intangible Assets4.51
Tax Assets, Noncurrent1.24
Other Assets, Noncurrent3.38
Total Assets11.16
Liabilities
Accounts Payable4.18
Derivative Liability LI0.00
Other Liabilities, Current0.00
Total Current Liabilities6.06
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent1.24
Other liabilities, Noncurrent0.63
Total Liabilities6.06
Stockholders' Equity
Other Equity0.00
Common Stockholder's Equity9.48
Total Stockholder's Equity5.10
Liabilities & Stockholder's Equity11.16
4 historic quarters locked

Sign in to unlock the full Quantum Biopharma Ltd balance sheet history.

About Quantum Biopharma Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001185185-26-001069

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.